Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 13,989 | 12,051 | 11,457 | 20,257 | 12,134 |
| Operating Income | -13,989 | -12,051 | -11,457 | -20,257 | -12,134 |
| Other Income | 425 | 201 | 336 | -7,167 | 175 |
| Pre-tax Income | -13,564 | -11,850 | -11,122 | -27,424 | -11,958 |
| Income Tax | N/A | N/A | N/A | N/A | -531 |
| Net Income Continuous | -13,564 | -11,850 | -11,122 | -27,424 | -11,428 |
| Net Income | $-13,564 | $-11,850 | $-11,122 | $-27,424 | $-11,428 |
| EPS Basic Total Ops | -10.36 | -96.78 | -212.00 | -851.25 | -375.00 |
| EPS Basic Continuous Ops | -10.36 | -96.81 | -211.99 | -851.18 | -372.99 |
| EPS Diluted Total Ops | -10.36 | -96.78 | -212.00 | -851.25 | -375.00 |
| EPS Diluted Continuous Ops | -10.36 | -96.81 | -211.99 | -851.18 | -372.99 |
| EPS Diluted Before Non-Recurring Items | -10.59 | -96.75 | -212.00 | -625.00 | -375.00 |
| EBITDA(a) | $-13,987 | $-12,050 | $-11,457 | $-19,353 | $-11,343 |